Zhangzhou Development: Subsidiary Participated Fund Completes Registration with China Securities Investment Fund Association

The development announcement of Zhangzhou stated that Talent Group, a subsidiary, as a limited partner, jointly invested 110 million yuan with other partners to establish the Zhangzhou Regenerative Medicine Industry Investment Fund partnership enterprise. Talent Group contributed 10 million yuan, accounting for 9.09%. Recently, the fund has completed the registration procedures with the China Securities Investment Fund Industry Association and obtained the "Private Equity Investment Fund Filing Certificate" on May 21, 2026. The fund manager is Zhangzhou Zhanxin Entrepreneurship Investment Fund Management Co., Ltd., and the custodian is Bank of China Limited.